Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma

J Thorac Oncol. 2015 Jun;10(6):e50-2. doi: 10.1097/JTO.0000000000000538.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Kommentar

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • ErbB Receptors / genetics*
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Mutation, Missense / genetics*
  • Quinazolines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Quinazolines
  • ErbB Receptors